Pharmacists Perspective

• Yes, Patients Are Getting More Complicated   It's not your imagination. Those problem lists are getting longer all the time, but the resources to deal with them are shrinking.
  Medscape, January 08, 2024
• Experiencing the Evolution of Early NSCLC Treatment   Jared Weiss, MD, reflects on his first encounter in training with a patient with early NSCLC and how the treatment landscape has rapidly changed since then.
  Medscape, January 08, 2024
• Cannabis for Psychiatric Disorders? Experts Weigh In   Steve Strakowski, Leslie Hulvershorn, and Christopher Hammond discuss the role of cannabis in psychiatric disorders.
  Medscape Psychiatry, January 08, 2024
• The Microbiome: It's What's Inside That Counts   The microbiome is the constellation of microscopic organisms that call the human body home, and its clinical implications are becoming increasingly clear to physicians.
  Medscape Gastroenterology, January 05, 2024
• Jan 05 2024 This Week in Cardiology   Neuro-modulation in HF, private equity owned hospitals, HCM, SCD and ICD re-evaluated, and peer review are the topics John Mandrola, MD, discusses in this week's podcast.
  theheart.org on Medscape, January 05, 2024
• Do Statins Offset Venous Thrombosis Risk With Hormone Therapy?   Statins might offer a way to reduce the risk for a potentially serious adverse effect of hormone therapy.
  Medscape Ob/Gyn, January 05, 2024
• Changes in the Treatment Landscape of Early-Stage Non-Small Cell Lung Cancer   Narjust Florez, MD, reflects on the significant changes in the treatment landscape of early-stage non-small cell lung cancer in recent years.
  Medscape, January 04, 2024
• Top Studies in Neurology From 2023   Christoph Diener discusses 10 top neurology studies from 2023 covering new drugs for Alzheimer's disease and advances in migraine.
  Medscape Neurology, January 04, 2024
• 5 Things to Know About Antifungal Therapeutic Drug Monitoring Antifungal therapeutic drug monitoring is a useful but underutilized tool in antifungal stewardship, experts say.
  CDC Expert Commentary, January 03, 2024
• Myelofibrosis Highlights From ASH 2023   Key studies on myelofibrosis, presented at ASH 2023, include the phase 3 MANIFEST-2 study, the phase 3 Transform-1 study, and multiple studies on treating anemia in myelofibrosis.
  Medscape, January 02, 2024
• Clinical Takeaways in Thrombocytopenia From ASH 2023   Clinical takeaways in immune thrombocytopenia (ITP) from ASH 2023 include efficacy of novel therapies, infection risk in chronic ITP, and ITP effects during pregnancy, as reported by Dr Howard Liebman.
  Medscape, January 02, 2024
• Triple Negative Breast Cancer e-Tumor Boards: Case 3: PD-L1 Negative TNBC with Homologous Recombination Deficiency   This case focuses on a patient with metastatic triple negative breast cancer which was initially HER2-positive.
  Medscape, January 02, 2024
• Key Abstracts in HER2-Positive Breast Cancer From SABCS 2023   Highlights in HER2+ breast cancer from SABCS 2023 include data from the HER2CLIMB-02 trial of tucatinib plus T-DM1 and a 9-year follow-up of the KATHERINE trial, as discussed by Dr Harold Burstein.
  Medscape, January 02, 2024
• Topics Cardiologists Love to Hate: MOC and AI   Bob Harrington and Mike Gibson discuss two of the hottest topics in cardiology and medicine for 2023: a proposed alternative to the maintenance of certification process, and artificial intelligence.
  theheart.org on Medscape, December 29, 2023
• Paroxysmal Nocturnal Hemoglobinuria Highlights From ASH 2023   Key studies on paroxysmal nocturnal hemoglobinuria presented at ASH 2023 include data on emerging therapies and a bifunctional C5 antibody factor H fusion protein.
  Medscape, December 28, 2023
• Phase 1 Trials: Are We Using Optimal Drug Dose Schedules?   David J. Kerr, CBE, MD, DSc, discusses considerations for dosing schedules in Phase 1 trials.
  Medscape Oncology, December 28, 2023
• Advances in Acute Lymphoblastic Leukemia From ASH 2023   Chemotherapy-free regimens in Philadelphia chromosome–positive acute lymphoblastic leukemia and optimization of combination therapies are among advances from ASH 2023 chosen by Dr Hagop Kantarjian.
  Medscape, December 28, 2023
• Most Popular Stories of 2023: Primary Care Edition New vaccines, sex and older adults, blood pressure targets, and physician shortage topped our list of most popular stories.
  Medscape Family Medicine, December 27, 2023
• Highlights in HR-Positive Breast Cancer From SABCS 2023   Highlights in HR+/HER2- breast cancer from SABCS 2023 include the INAVO120 trial of novel PI3K inhibitor inavolisib and 3-year follow-up data from the NATALEE trial, as reported by Dr Harold Burstein.
  Medscape, December 27, 2023
• Are You Employing Genetic Testing Correctly for CRC?   The latest guidelines and data support wider use of germline testing for certain patients, says Dr David Johnson.
  Medscape Gastroenterology, December 27, 2023
• Supercharge Your Medical Practice With ChatGPT An expert on artificial intelligence in oncology describes why, and how, to integrate ChatGPT into your clinical practice.
  Medscape Oncology, December 13, 2023